📊 Score Breakdown
Offering Ability
20
Cash Runway
25
Float Risk
5
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
7%
🔄 Reverse Split
15%
• 52-week low $0.96 has breached $1
💹 Market Data
Market Cap$229.11M
Shares Outstanding99.18M
Float94.77M
Cash$117.63M
Debt$26.95M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 1.6% shares (2025Q4 vs prior)
122 institutional holders · 38.43M shares
#1
Pfizer Inc
4.69M shares
#2
VANGUARD GROUP INC
4.30M shares
#3
Kynam Capital Management, LP
2.50M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest7.12M
Days to Cover4.3
% of Float7.5%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2021
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CRBU
📊 CRBU FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CRBU Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.